(redirected from nucleoside reverse transcriptase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
NRTINucleoside Reverse Transcriptase Inhibitor (therapy)
NRTINeighborhood Reinvestment Training Institute
NRTINukleosidische Reverse Transkriptase Inhibitoren (German: Nucleoside Reverse Transcriptase Inhibitors; AIDS therapy)
NRTINational Retail Traffic Index (ShopperTrak)
NRTINatural Resources Training Institute (Bhutan)
References in periodicals archive ?
Reverset appears to be an excellent addition to our armamentarium of nucleoside reverse transcriptase inhibitors.
The FDA approves the nucleoside reverse transcriptase inhibitor (NRTI), lamivudine (Epivir, 3TC), by accelerated approval.
In December, Bristol-Myers Squibb and Gilead Sciences announced that they will work together to develop a fixed-dose combination of Sustiva, a non-nucleoside reverse transcriptase inhibitor ("non-nuke"), and Truvada, a combination pill containing the nucleoside reverse transcriptase inhibitor ("nuke") Emtriva and the nucleotide reverse transcriptase inhibitor Viread.
To be marketed under the Emtriva name, the medicine belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class of AIDS drugs.
In the first 6 months of therapy among patients on a single nucleoside reverse transcriptase inhibitor, high AST and ALT levels were associated with severe hepatotoxicity (odds ratio [OR] of 2.
According to Chimerix deal, Merck will have to develope and commercialize CMX157, an investigational oral nucleoside reverse transcriptase inhibitor which is presently in Phase I clinical development.
The company said that the first new indication permits the use of Viread in combination with other antiretroviral agents for the treatment of HIV-1 infected pediatric patients aged two to less than 18 years with nucleoside reverse transcriptase inhibitor (NRTI) resistance or toxicities precluding the use of first line pediatric agents.
Full browser ?